California DFPI revokes BlockFi's license for multiple violations, including failure to evaluate borrowers' ability to repay ...

Nuveen AMT-Free Municipal Credit Income Fund's high leverage and potential mixture of lower credit quality exposure offer ...

In September 2024, Cidara initiated a randomized, double-blind, controlled Phase 2b trial targeting enrollment of 5,000 ...

According to KPMG Private Enterprise's Venture Pulse report, despite continued uncertainty in the market, AI continued to see incredibly strong VC investment in the US during Q3'24, led by a $1.5 ...

HEPLISAV-B vaccine is the first and only adult hepatitis B vaccine approved in the U.S., the European Union and Great Britain that enables series completion with only two doses in one month. Hepatitis ...

(NYSE American: GSAT) ("Globalstar" or the "Company") today announced its financial results for the third quarter ended September 30, 2024. "Globalstar reported s ...

Revenue of $621.4 million, an increase of $110.4 million or 21.6%, from the three months ended September 30, 2023.Net loss attributable to common shareholders of Evolent Health, Inc. of $(31.2) ...

Company expects to commence Phase 3 trial of Descartes-08 in patients with myasthenia gravis in 1H2025 following recent meeting with U.S. Food ...

Non-GAAP financial information excludes the after-tax impact of approximately $0.45 per diluted share related to highlighted ...

("Kalo", "Kalo Gold" or the "Company") is pleased to provide an exploration update on its 100% owned, 370 sq km Vatu Aurum ...

Total revenues decreased by 13% in the third quarter of 2024 to $29.0 million from $33.2 million in the third quarter of 2023 ...

Third Quarter 2024 Results All amounts expressed in U.S. dollars TORONTO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Barri ...